# Philippines: open a lawful research pathway before building the center
Legal feasibility proposal · Product-specific authorizations required. Section 16 of Republic Act 9165 contemplates medical laboratories and research centers working with cannabis for medical experiments and new medicines under Dangerous Drugs Board guidelines. That provision is a starting point for legal analysis, not a blanket operating permit. Philippine counsel should obtain written guidance on the exact activities, products, institutions, and authorizations contemplated by the proposal.
Canonical page: https://givegigs.com/wiki/necro-chapter-cannabis-philippines-law
Last updated: 2026-11-09T18:58:12.584Z
Parent topic: [necromancer-cannabis](https://givegigs.com/wiki/necromancer-cannabis)
## Contents
- [Overview](#wiki-section-overview-1)
- [Chapter notes](#wiki-section-chapter-notes-2)
- [Dossier section](#wiki-section-dossier-link-3)
## Overview
Legal feasibility proposal · Product-specific authorizations required. This page expands the “Philippines: open a lawful research pathway before building the center” chapter in the cannabis collection.
## Chapter notes
Section 16 of Republic Act 9165 contemplates medical laboratories and research centers working with cannabis for medical experiments and new medicines under Dangerous Drugs Board guidelines. That provision is a starting point for legal analysis, not a blanket operating permit. Philippine counsel should obtain written guidance on the exact activities, products, institutions, and authorizations contemplated by the proposal.
Request a regulatory consultation involving DOH, the Philippine FDA, DDB, PDEA, and DOST-PCHRD as appropriate. Map permissions for supply, importation, possession, storage, clinical administration, disposal, and any proposed cultivation separately. For an investigational-product trial, establish the applicable FDA pathway and independent ethics review before recruitment. A US authorization would not replace Philippine permission.
Prepare an updated legislative memorandum for medical access and a separate assessment of broader cannabis legalization, including treaty obligations. Record the date and status of each bill from the current congressional docket. Do not advertise a proposed bill, compassionate access arrangement, research exemption, or special economic zone as nationwide legalization or permission for cannabis tourism.
## Dossier section
[Open this exact section in the Necromancer dossier](/necromancer#cannabis-philippines-law). The original chapter status is “Legal feasibility proposal · Product-specific authorizations required.”
## Sources
- [Republic Act No\. 9165: Comprehensive Dangerous Drugs Act](https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/1435)
- [AO 2020-0010: Regulations on the Conduct of Clinical Trials](https://www.fda.gov.ph/administrative-order-no-2020-0010-regulations-on-the-conduct-of-clinical-trials-for-investigational-products/)
---
This article is collaboratively maintained. Check the canonical page and cited sources for the latest context.